Please sign in to follow a disease.
Thyroid gland disorder
MONDO:0003240A disease involving the thyroid gland.
Also known as: disease of thyroid gland, disease or disorder of thyroid gland, disorder of thyroid gland, thyroid disease, thyroid gland disease, thyroid gland disease or disorder, thyroid gland diseases, thyroid gland disorder
538 clinical trials for this condition and its sub-types, 96 tagged with Thyroid gland disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Thyroid gland disorder
-
Thyroid tumor 36 trials · 366 incl. sub-types
5 sub-types
- Thyroid cancer 166 trials · 328 incl. sub-types Sub-types →
- Benign thyroid gland neoplasm 21 trials · 26 incl. sub-types Sub-types →
- TSH producing pituitary tumor 0 trials · 2 incl. sub-types Sub-types →
- Familial thyroglossal duct cyst 2 trials
- Thyroid hyalinizing trabecular adenoma 0 trials
-
Goiter 12 trials · 102 incl. sub-types
7 sub-types
- Toxic diffuse goiter 0 trials · 53 incl. sub-types Sub-types →
- Nodular goiter 36 trials · 43 incl. sub-types Sub-types →
- Endemic goiter 4 trials
- Nontoxic goiter 1 trial
- Substernal goiter 1 trial
- Dyshormonogenic goiter 0 trials
- Lingual goiter 0 trials
-
Hyperthyroidism 27 trials · 70 incl. sub-types
10 sub-types
- Primary hyperthyroidism 1 trial · 59 incl. sub-types Sub-types →
- Toxic diffuse goiter 0 trials · 53 incl. sub-types Sub-types →
- Generalized resistance to thyroid hormone 1 trial · 2 incl. sub-types Sub-types →
- Secondary hyperthyroidism 0 trials · 2 incl. sub-types Sub-types →
- Thyrotoxicosis 2 trials Sub-types →
- Familial gestational hyperthyroidism 0 trials
- Familial hyperthyroidism due to mutations in TSH receptor 0 trials
- Hyperthyroxinemia, familial dysalbuminemic 0 trials
- Selective pituitary resistance to thyroid hormone 0 trials
- Thyroid crisis 0 trials
-
Thyroiditis 1 trial · 62 incl. sub-types
3 sub-types
- Autoimmune thyroid disease 8 trials · 62 incl. sub-types Sub-types →
- Acute thyroiditis 0 trials · 2 incl. sub-types Sub-types →
- Suppurative thyroiditis 0 trials
-
Hypothyroidism 48 trials · 60 incl. sub-types
6 sub-types
- Congenital hypothyroidism 10 trials · 14 incl. sub-types Sub-types →
- Postsurgical hypothyroidism 1 trial
- Iodine hypothyroidism 0 trials
- Myxedema 0 trials
- Myxedema coma 0 trials
- Myxedema heart disease 0 trials
-
Inherited thyroid metabolism disease 0 trials · 8 incl. sub-types
2 sub-types
- Familial thyroid dyshormonogenesis 1 trial · 4 incl. sub-types Sub-types →
- Thyroid hormone resistance syndrome 3 trials · 4 incl. sub-types Sub-types →
-
C-cell hyperplasia 0 trials
-
Atrophy of thyroid 0 trials
-
Euthyroid sick syndrome 0 trials
-
Hyperthyroxinemia 0 trials
3 sub-types
-
Thyrocalcitonin secretion disease 0 trials
-
Thyroid malformation 0 trials
Most studied deeper sub-types
-
Liquid vs crushed pills: which works better for babies with low thyroid?
Disease control Stopped earlyThis study compared a liquid form of thyroid medication (Tirosint-SOL) to crushed tablets in 34 infants with congenital hypothyroidism. The goal was to see which form helps maintain normal thyroid hormone levels more easily. However, the study was stopped early, so firm conclusio…
Phase 4 • Sponsor: IBSA Institut Biochimique SA • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pazopanib dose hunt in frail seniors halted early
Disease control Stopped earlyThis phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…
Phase 1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental cancer combo shows early promise but study halted
Disease control Stopped earlyThis early-phase trial tested a new drug called nanrilkefusp alfa, which helps activate immune cells, both alone and combined with the immunotherapy pembrolizumab. It included 115 people with various advanced solid tumors that had stopped responding to standard treatments. The st…
Phase 1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental combo targets deadly thyroid cancer
Disease control Stopped earlyThis phase 2 trial tested whether the immunotherapy drug pembrolizumab, given after radiation therapy, could help control anaplastic thyroid cancer that is still in the neck. Only 6 patients were enrolled before the study was stopped early. The goal was to see how long patients l…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immunotherapy combo tested for tough thyroid cancers
Disease control Stopped earlyThis phase II trial tested two immunotherapy drugs, durvalumab and tremelimumab, in 79 patients with advanced thyroid cancer that had progressed despite treatment. The goal was to see if the combination could slow or stop cancer growth. The study was terminated early, so the full…
Phase 2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug targets genetic weakness in tough cancers
Disease control Stopped earlyThis phase 2 trial tested the drug tovorafenib (DAY101) in 23 people aged 12 and older with recurrent or progressive solid tumors that have specific genetic changes in the MAPK pathway. The goal was to see how many patients' tumors shrank or disappeared. The study was terminated …
Phase 2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Experimental cancer pill targets Hard-to-Treat gene mutations
Disease control Stopped earlyThis early study tested an experimental oral drug called IK-595 in people with advanced solid tumors that have specific RAS or RAF gene mutations. The goal was to check safety, dosing, and early signs of tumor shrinkage. The study was terminated before completion, so full results…
Phase 1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated Jun 26, 2026 19:17 UTC
-
A radioactive clue that could spare thousands from thyroid surgery
Diagnosis Stopped earlyThis trial tests whether a special imaging scan using a small amount of radioactive iodine (iodine-123) can tell the difference between benign and cancerous thyroid nodules before surgery. Currently, biopsy alone can't always make that call, so many people undergo surgery just to…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
New scan spots hidden thyroid cancer better?
Diagnosis Stopped earlyThis study tested a new type of PET scan (called 68Ga-MY6349) that targets a protein called Trop-2 on cancer cells. It was used in 149 adults with thyroid cancer to see if it could find cancer that had come back or spread. The results were compared to the standard FDG-PET scan to…
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
New Hand-Held imager aims to prevent accidental parathyroid damage in thyroid surgery
Diagnosis Stopped earlyThis early study tested a hand-held imaging device to help surgeons identify parathyroid glands during thyroid surgery. The parathyroid glands are small and hard to see, and if accidentally removed or damaged, can cause low calcium levels and other complications. The device uses …
Phase 1 • Sponsor: OPTOSURGICAL, LLC • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
New ultrasound technique aims to spot cancer without radiation
Diagnosis Stopped earlyThis study tested a new 3D ultrasound technique called acoustic angiography to improve imaging of breast and thyroid tumors. Researchers planned to enroll 45 people, including healthy volunteers and patients scheduled for biopsy. The study was stopped early due to funding problem…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Diabetes drug may ease thyroid treatment side effects
Symptom relief Stopped earlyThis small pilot study tested whether metformin, a common diabetes drug, could reduce side effects like dry mouth and taste changes from radioactive iodine treatment in people with thyroid cancer. Only 13 people took part, and the study was stopped early. The goal was to see if m…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain fatigue after thyroid disease: immune system may be to blame
Knowledge-focused Stopped earlyThis study investigates why some people with Graves' disease continue to feel mentally fatigued even after their thyroid levels return to normal. Researchers will compare blood and spinal fluid from 180 participants—60 with mental fatigue, 60 without, and 60 healthy controls—to f…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Could a common virus trigger thyroid troubles?
Knowledge-focused Stopped earlyThis study investigated whether polyomaviruses (a type of common virus) are found more often in people with autoimmune thyroiditis or goiters. Researchers compared virus presence in blood, urine, and thyroid tissue from 49 patients undergoing thyroid surgery. The goal was to see …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Hunt for hidden thyroid cancer genes ends early
Knowledge-focused Stopped earlyThis study looked for new genes that might increase the risk of developing differentiated thyroid cancer. Researchers planned to analyze the complete DNA of people with thyroid cancer and their family members. The study was stopped early and involved 34 participants.
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC